Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

CUSIP: 74275C304

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
55,555,556
Total 13F shares
372,611
Share change
+201,822
Total reported value
$75,916
Price per share
$0.20
Number of holders
12
Value change
+$30,207
Number of buys
9
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 74275C304?
CUSIP 74275C304 identifies PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) as of Q2 2025

As of 30 Jun 2025, Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 372,611 shares. The largest 10 holders included Virtu Financial LLC, UBS Group AG, Alpine Global Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Cubist Systematic Strategies, LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, Sequoia Financial Advisors, LLC, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN. This page lists 12 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.